| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.4 | 8e-11 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |